首页 > 最新文献

Problemy endokrinologii最新文献

英文 中文
[Survival predictors in patients with ectopic acth syndrome]. [异位acth综合征患者的生存预测]。
Q4 Medicine Pub Date : 2022-08-15 DOI: 10.14341/probl13144
O O Golounina, Zh/ E Belaya, L Ya Rozhinskaya, M Yu Pikunov, A A Markovich, L K Dzeranova, E I Marova, N S Kuznetsov, V V Fadeev, G A Melnichenko, I I Dedov

Aim: To determine significant factors affecting the survival of patients with ectopic ACTH syndrome (EAS).

Materials and methods: A multi-center, observational study with a retrospective analysis of patients with EAS. The end point of the study was the fatal outcome of patients from various causes. In order to identify predictors of survival or mortality, univariate and multifactorial Cox regression analyses were carried out. ROC-analysis was used to determine the prognostic threshold values of individual predictors. The survival analysis was carried out using the Kaplan-Mayer method. Statistical data processing was carried out by using IBM SPSS Statistics 23.

Results: The age of patients at the time of diagnosis ranged from 12 to 76 years (Me 40 years [28;54]). The age of the studied population was 55 years [38; 64] for women and 42 years [32; 54] for men. The median period of observation was 50 months [13;91], with a maximum follow-up of 382 months. 92 patients (60,9%) had bronchopulmonary NET, 17 (11,3%) - thymic carcinoid, 8 - pancreatic NET, 5 -pheochromocytoma, 1- cecum NET, 1- appendix carcinoid tumor, 1 - medullary thyroid cancer and 26 (17,2%) patients had an occult NET. The primary tumor was removed in 101 patients (66,9%). Bilateral adrenalectomy was performed in 42 (27,8%) cases. Metastases were revealed in 23,2% (n=35) of patients. Relapse of the disease was observed in 24,4%, long-term remission was preserved in 64 patients (74,4%). Death occurred in 42 patients (28%). The average age of survivors was 47,0±15,2 versus 53,5±15,6 years for the deceased (p=0,022). The average survival time from diagnosis for the deceased was 32 months, Me 16,5 months [7;54]. Multivariate analysis revealed that the following factors have a direct impact on survival: age of diagnosis ≥51 years (OR 4,493; 95% CI 2,056-9,818, p<0,001), bronchopulmonary neuroendocrine tumor (NET) (OR 0,281; 95% CI 0,119-0,665, p=0,004), the presence of distant metastases (OR 2,489; 95% CI 1,141-5,427, p=0,022), late-night salivary cortisol (LNSC) ≥122,2 nmol/L (OR 2,493; 95% CI 1,014-6,128, p=0,047).

Conclusion: The prognosis of patients with EAS is influenced by the age of diagnosis, NET localization, distant metastases and level of LNSC. The most common cause of ectopic ACTH syndrome was bronchopulmonary NET which was associated with the best survival rate.

目的:确定影响异位促肾上腺皮质激素综合征(EAS)患者生存的重要因素:对EAS患者进行回顾性分析的多中心观察研究。研究的终点是患者因各种原因导致的死亡结果。为了确定存活率或死亡率的预测因素,进行了单因素和多因素 Cox 回归分析。ROC分析用于确定单个预测因子的预后阈值。生存分析采用 Kaplan-Mayer 法进行。统计数据处理采用 IBM SPSS Statistics 23:患者确诊时的年龄从 12 岁到 76 岁不等(平均 40 岁 [28;54])。研究对象的年龄为女性 55 岁 [38; 64],男性 42 岁 [32; 54]。观察期的中位数为 50 个月 [13;91],最长随访时间为 382 个月。92名患者(60.9%)患有支气管肺癌,17名患者(11.3%)患有胸腺类癌,8名患者患有胰腺NET,5名患者患有嗜铬细胞瘤,1名患者患有盲肠NET,1名患者患有阑尾类癌,1名患者患有甲状腺髓样癌,26名患者(17.2%)患有隐匿性NET。101名患者(66.9%)的原发肿瘤被切除。42例(27.8%)患者进行了双侧肾上腺切除术。23.2%的患者(35例)发现了转移灶。24.4%的患者病情复发,64名患者(74.4%)病情长期缓解。42名患者(28%)死亡。幸存者的平均年龄为(47.0±15.2)岁,而死亡者的平均年龄为(53.5±15.6)岁(P=0.022)。从确诊到死亡的平均存活时间为 32 个月,我为 16.5 个月 [7;54]。多变量分析显示,以下因素对存活率有直接影响:诊断年龄≥51岁(OR 4,493; 95% CI 2,056-9,818, p<0,001)、支气管肺神经内分泌肿瘤(NET)(OR 0,281;95%CI为0,119-0,665,P=0,004)、存在远处转移(OR为2,489;95%CI为1,141-5,427,P=0,022)、深夜唾液皮质醇(LNSC)≥122,2 nmol/L(OR为2,493;95%CI为1,014-6,128,P=0,047)。结论EAS患者的预后受诊断年龄、NET定位、远处转移和LNSC水平的影响。异位ACTH综合征最常见的病因是支气管肺NET,其存活率最高。
{"title":"[Survival predictors in patients with ectopic acth syndrome].","authors":"O O Golounina, Zh/ E Belaya, L Ya Rozhinskaya, M Yu Pikunov, A A Markovich, L K Dzeranova, E I Marova, N S Kuznetsov, V V Fadeev, G A Melnichenko, I I Dedov","doi":"10.14341/probl13144","DOIUrl":"10.14341/probl13144","url":null,"abstract":"<p><strong>Aim: </strong>To determine significant factors affecting the survival of patients with ectopic ACTH syndrome (EAS).</p><p><strong>Materials and methods: </strong>A multi-center, observational study with a retrospective analysis of patients with EAS. The end point of the study was the fatal outcome of patients from various causes. In order to identify predictors of survival or mortality, univariate and multifactorial Cox regression analyses were carried out. ROC-analysis was used to determine the prognostic threshold values of individual predictors. The survival analysis was carried out using the Kaplan-Mayer method. Statistical data processing was carried out by using IBM SPSS Statistics 23.</p><p><strong>Results: </strong>The age of patients at the time of diagnosis ranged from 12 to 76 years (Me 40 years [28;54]). The age of the studied population was 55 years [38; 64] for women and 42 years [32; 54] for men. The median period of observation was 50 months [13;91], with a maximum follow-up of 382 months. 92 patients (60,9%) had bronchopulmonary NET, 17 (11,3%) - thymic carcinoid, 8 - pancreatic NET, 5 -pheochromocytoma, 1- cecum NET, 1- appendix carcinoid tumor, 1 - medullary thyroid cancer and 26 (17,2%) patients had an occult NET. The primary tumor was removed in 101 patients (66,9%). Bilateral adrenalectomy was performed in 42 (27,8%) cases. Metastases were revealed in 23,2% (n=35) of patients. Relapse of the disease was observed in 24,4%, long-term remission was preserved in 64 patients (74,4%). Death occurred in 42 patients (28%). The average age of survivors was 47,0±15,2 versus 53,5±15,6 years for the deceased (p=0,022). The average survival time from diagnosis for the deceased was 32 months, Me 16,5 months [7;54]. Multivariate analysis revealed that the following factors have a direct impact on survival: age of diagnosis ≥51 years (OR 4,493; 95% CI 2,056-9,818, p&lt;0,001), bronchopulmonary neuroendocrine tumor (NET) (OR 0,281; 95% CI 0,119-0,665, p=0,004), the presence of distant metastases (OR 2,489; 95% CI 1,141-5,427, p=0,022), late-night salivary cortisol (LNSC) ≥122,2 nmol/L (OR 2,493; 95% CI 1,014-6,128, p=0,047).</p><p><strong>Conclusion: </strong>The prognosis of patients with EAS is influenced by the age of diagnosis, NET localization, distant metastases and level of LNSC. The most common cause of ectopic ACTH syndrome was bronchopulmonary NET which was associated with the best survival rate.</p>","PeriodicalId":20433,"journal":{"name":"Problemy endokrinologii","volume":"68 6","pages":"30-42"},"PeriodicalIF":0.0,"publicationDate":"2022-08-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939959/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9299174","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Contraception in adolescents with obesity and diabetes mellitus]. [肥胖和糖尿病青少年的避孕]。
Q4 Medicine Pub Date : 2022-08-10 DOI: 10.14341/probl12760
M R Shaydullina, F V Valeeva, A F Soubchankoulova, P A Khusieva

Today most adolescents have their first sexual experience at the age of 15-19. However, only 44% of girls and young women (15-24 years old) report about contraception at that moment. A decision on pregnancy in adolescence is a difficult choice and any scenario may cause serious medical and social problems. Complications after an artificial abortion have a negative impact on a woman's fertility. Diabetes mellitus type 1 and arterial hypertension accompanied with obesity within the metabolic syndrome are defined by the World Health Organization (WHO) as diseases, which increase risk of an unplanned pregnancy. The article consoders problems of interaction of a doctor and a teenage girl with endocrinopathy, when discussing her sexual health, the analysis of the literature reflecting the influence of contraception on the course of the underlying pathology is presented. The authors formed a list of drugs acceptable for use in diabetes and obesity based on assessment of risks and preferences from the use of different methods of fertility control. The work contains information about the procedure of starting contraception, the rules of future dynamic monitoring of the patient.

今天,大多数青少年在15-19岁时有了第一次性经历。然而,只有44%的女孩和年轻妇女(15-24岁)报告在那个时候采取了避孕措施。在青春期决定怀孕是一个艰难的选择,任何情况下都可能导致严重的医疗和社会问题。人工流产后的并发症对妇女的生育能力有负面影响。世界卫生组织(世卫组织)将1型糖尿病和伴有代谢综合征肥胖的动脉高血压定义为增加意外怀孕风险的疾病。本文讨论了一位医生和一位患有内分泌疾病的少女在讨论她的性健康问题时的互动问题,并对反映避孕对潜在病理过程影响的文献进行了分析。作者根据使用不同生育控制方法的风险和偏好评估,列出了糖尿病和肥胖症患者可接受的药物清单。这项工作包括关于开始避孕程序的信息,病人未来动态监测的规则。
{"title":"[Contraception in adolescents with obesity and diabetes mellitus].","authors":"M R Shaydullina,&nbsp;F V Valeeva,&nbsp;A F Soubchankoulova,&nbsp;P A Khusieva","doi":"10.14341/probl12760","DOIUrl":"https://doi.org/10.14341/probl12760","url":null,"abstract":"<p><p>Today most adolescents have their first sexual experience at the age of 15-19. However, only 44% of girls and young women (15-24 years old) report about contraception at that moment. A decision on pregnancy in adolescence is a difficult choice and any scenario may cause serious medical and social problems. Complications after an artificial abortion have a negative impact on a woman's fertility. Diabetes mellitus type 1 and arterial hypertension accompanied with obesity within the metabolic syndrome are defined by the World Health Organization (WHO) as diseases, which increase risk of an unplanned pregnancy. The article consoders problems of interaction of a doctor and a teenage girl with endocrinopathy, when discussing her sexual health, the analysis of the literature reflecting the influence of contraception on the course of the underlying pathology is presented. The authors formed a list of drugs acceptable for use in diabetes and obesity based on assessment of risks and preferences from the use of different methods of fertility control. The work contains information about the procedure of starting contraception, the rules of future dynamic monitoring of the patient.</p>","PeriodicalId":20433,"journal":{"name":"Problemy endokrinologii","volume":"68 6","pages":"137-145"},"PeriodicalIF":0.0,"publicationDate":"2022-08-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939967/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10807157","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
[Role of preoperative visualization in the choice of surgery for primary hyperparathyroidism]. [术前可视化在原发性甲状旁腺功能亢进症手术选择中的作用]。
Q4 Medicine Pub Date : 2022-08-08 DOI: 10.14341/probl13096
D M Buzanakov, I V Sleptsov, A A Semenov, R A Chernikov, K Y Novokshonov, Yu V Karelina, N I Timofeeva, L G Yanevskaya, T A Dzhumatov

Background: Precise localization of abnormal parathyroid glands is important for a successful surgery for primary hyperparathyroidism (PHPT). While a large number of patients can be successfully treated with the focused parathyroidectomy, there is a considerable rate of the persistent PHPT mostly because of undetected multiglandular disease (MGD).

Aim: The aim of the study was to evaluate the meaning of preoperative visualization data for planning the surgery for patients with PHPT.

Materials and methods: The study was conducted at SPBU Hospital in 2017-2018. 810 patients who underwent a primary surgery for PHPT were included in the study. Preoperative imaging results were investigated and multivariative logistic regressions were calculated to assess the predictive values of preoperative data. The rate of cases with persistent disease and cases with MGD were compared between patients with different results of preoperative data.

Results: Age, sex, body mass index, negative results of preoperative US, MIBI and 4D CT were not independently associated with the higher risk of multiglandular disease. The larger number of performed preoperative visualization studies were associated with the higher risk of persistence. 37% cases of MGD were not identified preoperatively. There were 7 cases with previously unsuspected second adenomas found only due to bilateral neck exploration.

Conclusion: Any combination of preoperative visualization modalities was not able to rule out the MGD reliably. Efficacy of surgical treatment was not associated with the higher number of preoperative studies. Bilateral neck exploration may decrease the rate of the persistent hyperparathyroidism improving the identification of multiglandular disease.

背景:准确定位异常的甲状旁腺对于原发性甲状旁腺功能亢进症(PHPT)手术的成功非常重要。虽然大量患者可通过聚焦甲状旁腺切除术获得成功治疗,但仍有相当比例的原发性甲状旁腺功能亢进症(PHPT)持续存在,这主要是因为多腺体疾病(MGD)未被发现。研究目的:该研究旨在评估术前可视化数据对原发性甲状旁腺功能亢进症(PHPT)患者手术规划的意义:研究于2017-2018年在SPBU医院进行。研究纳入了 810 名接受 PHPT 初级手术的患者。对术前影像学结果进行调查,并计算多变量逻辑回归,以评估术前数据的预测价值。比较了术前数据结果不同的患者中疾病持续存在的病例比率和MGD病例比率:结果:年龄、性别、体重指数、术前 US、MIBI 和 4D CT 阴性结果与多腺疾病的高风险无独立关联。术前可视化检查次数越多,多腺疾病持续存在的风险越高。37%的多腺疾病病例在术前未被发现。有7个病例在双侧颈部探查时才发现先前未曾怀疑的第二腺瘤:结论:任何术前可视化方式的组合都无法可靠地排除多发性腺瘤。手术治疗的效果与术前检查次数的多少无关。双侧颈部探查可降低持续性甲状旁腺功能亢进的发生率,提高多腺疾病的识别率。
{"title":"[Role of preoperative visualization in the choice of surgery for primary hyperparathyroidism].","authors":"D M Buzanakov, I V Sleptsov, A A Semenov, R A Chernikov, K Y Novokshonov, Yu V Karelina, N I Timofeeva, L G Yanevskaya, T A Dzhumatov","doi":"10.14341/probl13096","DOIUrl":"10.14341/probl13096","url":null,"abstract":"<p><strong>Background: </strong>Precise localization of abnormal parathyroid glands is important for a successful surgery for primary hyperparathyroidism (PHPT). While a large number of patients can be successfully treated with the focused parathyroidectomy, there is a considerable rate of the persistent PHPT mostly because of undetected multiglandular disease (MGD).</p><p><strong>Aim: </strong>The aim of the study was to evaluate the meaning of preoperative visualization data for planning the surgery for patients with PHPT.</p><p><strong>Materials and methods: </strong>The study was conducted at SPBU Hospital in 2017-2018. 810 patients who underwent a primary surgery for PHPT were included in the study. Preoperative imaging results were investigated and multivariative logistic regressions were calculated to assess the predictive values of preoperative data. The rate of cases with persistent disease and cases with MGD were compared between patients with different results of preoperative data.</p><p><strong>Results: </strong>Age, sex, body mass index, negative results of preoperative US, MIBI and 4D CT were not independently associated with the higher risk of multiglandular disease. The larger number of performed preoperative visualization studies were associated with the higher risk of persistence. 37% cases of MGD were not identified preoperatively. There were 7 cases with previously unsuspected second adenomas found only due to bilateral neck exploration.</p><p><strong>Conclusion: </strong>Any combination of preoperative visualization modalities was not able to rule out the MGD reliably. Efficacy of surgical treatment was not associated with the higher number of preoperative studies. Bilateral neck exploration may decrease the rate of the persistent hyperparathyroidism improving the identification of multiglandular disease.</p>","PeriodicalId":20433,"journal":{"name":"Problemy endokrinologii","volume":"68 6","pages":"22-29"},"PeriodicalIF":0.0,"publicationDate":"2022-08-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939960/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9299178","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[The short test with hydrochlorothiazide in differential diagnosis between primary normocalcemic and secondary hyperparathyroidism for inpatient treatment]. [短期试验氢氯噻嗪在原发性正常血钙血症和继发性甲状旁腺功能亢进住院治疗中的鉴别诊断]。
Q4 Medicine Pub Date : 2022-08-05 DOI: 10.14341/probl13150
A K Eremkina, A R Elfimova, E A Aboisheva, E V Karaseva, M I Fadeeva, I S Maganeva, E V Kovaleva, A M Gorbacheva, E E Bibik, N G Mokrysheva

Background: Differential diagnosis between the normocalcemic primary hyperparathyroidism (nPHPT) and secondary hyperparathyroidism (SHPT) due to hypercalciuria remains a challenge.

Aim: The aim of this study was to investigate the capability of short test with hydrochlorothiazide for the differential diagnosis of nPHPT and SHPT.

Materials and methods: A retrospective study was conducted with the participation of 28 patients who underwent a functional test with thiazide diuretics during hospitalization in the Department of parathyroid glands pathology and mineral disorders of the Endocrinology Research Centre, Russia. Parameters of mineral metabolism were evaluated before and 3-5 days after taking hydrochlorothiazide 50 mg/day.

Results: According to baseline and dynamic biochemical evaluation patients were divided into 3 groups. Group 1 (n=21) included patients with confirmed PHPT, who reached hypercalcemia accompanying with an elevated level of iPTH (n=19) or an increased level of iPTH accompanying with normocalcemia (n=2). In group 1, baseline Caadj. was 2.48 mmol/l [2.47; 2.52], iPTH 107.5 pg/ml [86.8; 133.0], after short test - 2.63 mmol/l [2.59; 2.66] and 102.1 pg/ml [95,7; 124,1]. Group 2 included only one who was diagnosed with SHPT, a normal value of iPTH with concomitant normocalcemia was achieved after 4 days of hydrochlorothiazide therapy (baseline Caadj. 2.35 mmol/l, iPTH 74.5 pg/ml vs at 2.27 mmol/l and 50.7 pg/ml respectively). Patients with doubtful results of the test entered in group 3 (n=6), they did not achieve significant changes in the calcium and iPTH levels, so it was recommended to continue the test on an outpatient basis (baseline Caadj. 2.39 mmol/l [2.33;2.45], iPTH 97.0 pg/ml [83.1;117.0]); after short test - 2.47 mmol/l [2.42; 2.48] and 91.3 pg/ml [86.9; 124.0] respectively). Groups with PHPT and SHPT and doubtful results significantly differed from each other in Caadj (р=0.003, U-test, Bonferroni correction Р0=0.006), but not in iPTH, daily calciuria, eGFR, and phosphorus. There were no significant differences in the incidence of classical complications of PHPT.

Conclusion: The diagnosis of PHPT was confirmed in 21/28 patients 3-5 days after taking hydrochlorothiazide 50 mg/day. The obtained results are significant for the differential diagnosis in hospitalized patients with an unspecified genesis of hyperparathyroidism.

背景:高钙尿引起的常钙原发性甲状旁腺功能亢进症(nPHPT)和继发性甲状旁腺功能减退症(SHPT)的鉴别诊断仍然是一个挑战。目的:本研究的目的是探讨氢氯噻嗪短时间试验对nPHPT和SHPT的鉴别诊断能力。材料和方法:对28名患者进行了回顾性研究,这些患者在住院期间接受了噻嗪类利尿剂的功能试验内分泌研究中心,俄罗斯。结果:根据基线和动态生化评估,将患者分为3组。第1组(n=21)包括确诊为PHPT的患者,他们达到高钙血症并伴有iPTH水平升高(n=19)或iPTH水平增加并伴有正常血钙(n=2)。在第1组中,基线Caadj。为2.48 mmol/l[2.47;2.52],iPTH为107.5 pg/ml[86.8;133.0],短期试验后为-2.63 mmol/l[2.59;2.66]和102.1 pg/ml[95,7;124,1]。第2组仅包括一名被诊断为SHPT的患者,在氢氯噻嗪治疗4天后,iPTH的正常值并伴有正常血钙(基线Caadj.2.35 mmol/l,iPTH 74.5 pg/ml vs 2.27 mmol/l和50.7 pg/ml)。试验结果可疑的患者进入第3组(n=6),他们的钙和iPTH水平没有发生显著变化,因此建议在门诊基础上继续进行试验(基线Caadj.2.39 mmol/l[2.33;2.45],iPTH 97.0 pg/ml[83.1;117.0]);短期试验后分别为2.47 mmol/l[2.42;2.48]和91.3 pg/ml[86.9;124.0])。PHPT和SHPT组和可疑结果组在Caadj方面存在显著差异(р=0.003,U型检验,Bonferroni校正Р0=0.006),但在iPTH、每日钙尿、eGFR和磷方面没有差异。PHPT典型并发症的发生率无显著差异。结论:21/28例患者在服用氢氯噻嗪50mg/天后3-5天确诊为PHPT。所获得的结果对于不明原因的甲状旁腺功能亢进住院患者的鉴别诊断具有重要意义。
{"title":"[The short test with hydrochlorothiazide in differential diagnosis between primary normocalcemic and secondary hyperparathyroidism for inpatient treatment].","authors":"A K Eremkina,&nbsp;A R Elfimova,&nbsp;E A Aboisheva,&nbsp;E V Karaseva,&nbsp;M I Fadeeva,&nbsp;I S Maganeva,&nbsp;E V Kovaleva,&nbsp;A M Gorbacheva,&nbsp;E E Bibik,&nbsp;N G Mokrysheva","doi":"10.14341/probl13150","DOIUrl":"10.14341/probl13150","url":null,"abstract":"<p><strong>Background: </strong>Differential diagnosis between the normocalcemic primary hyperparathyroidism (nPHPT) and secondary hyperparathyroidism (SHPT) due to hypercalciuria remains a challenge.</p><p><strong>Aim: </strong>The aim of this study was to investigate the capability of short test with hydrochlorothiazide for the differential diagnosis of nPHPT and SHPT.</p><p><strong>Materials and methods: </strong>A retrospective study was conducted with the participation of 28 patients who underwent a functional test with thiazide diuretics during hospitalization in the Department of parathyroid glands pathology and mineral disorders of the Endocrinology Research Centre, Russia. Parameters of mineral metabolism were evaluated before and 3-5 days after taking hydrochlorothiazide 50 mg/day.</p><p><strong>Results: </strong>According to baseline and dynamic biochemical evaluation patients were divided into 3 groups. Group 1 (n=21) included patients with confirmed PHPT, who reached hypercalcemia accompanying with an elevated level of iPTH (n=19) or an increased level of iPTH accompanying with normocalcemia (n=2). In group 1, baseline Caadj. was 2.48 mmol/l [2.47; 2.52], iPTH 107.5 pg/ml [86.8; 133.0], after short test - 2.63 mmol/l [2.59; 2.66] and 102.1 pg/ml [95,7; 124,1]. Group 2 included only one who was diagnosed with SHPT, a normal value of iPTH with concomitant normocalcemia was achieved after 4 days of hydrochlorothiazide therapy (baseline Caadj. 2.35 mmol/l, iPTH 74.5 pg/ml vs at 2.27 mmol/l and 50.7 pg/ml respectively). Patients with doubtful results of the test entered in group 3 (n=6), they did not achieve significant changes in the calcium and iPTH levels, so it was recommended to continue the test on an outpatient basis (baseline Caadj. 2.39 mmol/l [2.33;2.45], iPTH 97.0 pg/ml [83.1;117.0]); after short test - 2.47 mmol/l [2.42; 2.48] and 91.3 pg/ml [86.9; 124.0] respectively). Groups with PHPT and SHPT and doubtful results significantly differed from each other in Caadj (р=0.003, U-test, Bonferroni correction Р0=0.006), but not in iPTH, daily calciuria, eGFR, and phosphorus. There were no significant differences in the incidence of classical complications of PHPT.</p><p><strong>Conclusion: </strong>The diagnosis of PHPT was confirmed in 21/28 patients 3-5 days after taking hydrochlorothiazide 50 mg/day. The obtained results are significant for the differential diagnosis in hospitalized patients with an unspecified genesis of hyperparathyroidism.</p>","PeriodicalId":20433,"journal":{"name":"Problemy endokrinologii","volume":"68 4","pages":"52-58"},"PeriodicalIF":0.0,"publicationDate":"2022-08-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9768719/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10500384","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Neonatal thyrotropin - indicatior of monitoring of iodine deficiency severity. What's level is considered a «cutoff point»?] 新生儿促甲状腺激素-监测碘缺乏严重程度的指示。什么水平被认为是“截止点”?]
Q4 Medicine Pub Date : 2022-07-31 DOI: 10.14341/probl12892
L A Suplotova, O B Makarova, A Troshina

Background: The issues of monitoring the effectiveness of iodine deficiency prevention programs are an important component in the process of iodine elimination. Neonatal thyrotropin (TSH) has been used as a criterion for the severity of iodine deficiency since 1994, however, the question of the "cut-off point" of the neonatal TSH level has been widely discussed in the recent literature.

Aim: Evaluate the criterion for neonatal hyperthyroidism above 5 mIU/l from the perspective of monitoring iodine deficiency and establish a «cut-off point» on the model of healthy pregnant women with adequate iodine status.

Materials and methods: A prospective study was conducted in a population of pregnant women in the city of Tyumen, with the formation of observation groups according to the level of iodine excretion in the urine - the main group (with adequate iodine status throughout the entire gestation period) and the comparison group (women with iodine levels less than 150 μg/l). The results of neonatal screening for congenital hypothyroidism in children of women participating in the study were evaluated. The frequency of neonatal TSH above 5mIU/l was assessed in the observation groups. ROC-analysis was performed and a «cut-off point» of the level of neonatal TSH was established as an indicator of iodine deficiency.

Results: The median urinary iodine concentration in the population of pregnant women in Tyumen was 159.05 μg/l, the incidence of goiter was 0.38%, the incidence of neonatal hyperthyroidism above 5 mIU/l was 2.88%, which characterizes adequate iodine intake in the pregnant population women. The frequency of neonatal TSH above 5 mIU/l in newborns from women from the main group was 1.47%, and in the comparison group - 9.3% (p = 0.076). ROC analysis revealed a threshold value of neonatal TSH of 2.77 mIU/l at the cut-off point, which corresponded to the highest value of the Youden index. Urinary iodine concentrations greater than 150 μg/l were predicted for nTSH values below this value.

Conclusion: Analysis of databases of neonatal screening for congenital hypothyroidism makes it possible to effectively, quickly and at minimal cost annually assess the iodine status in the population. The established «cut-off point» of neonatal TSH in the model of healthy pregnant women with adequate iodine intake in our work is 2.77 mIU/l, the absence of statistically significant differences in the incidence of neonatal hyperthyroidism above 5 mIU/l from women with different iodine status during pregnancy indicate the need to revise the existing threshold of 5 mIU/l and may be an incentive to conduct large-scale studies in regions with different iodine supply.

背景:监测碘缺乏症预防项目的有效性是碘消除过程中的一个重要组成部分。自1994年以来,新生儿促甲状腺激素(TSH)一直被用作碘缺乏严重程度的标准,然而,新生儿TSH水平的“分界点”问题在最近的文献中被广泛讨论。目的:从监测碘缺乏的角度评价5 mIU/l以上新生儿甲状腺功能亢进的判定标准,并建立碘状态充足的健康孕妇模型的“截断点”。材料与方法:对秋明市孕妇进行前瞻性研究,根据尿中碘的排泄水平分为观察组——主组(整个妊娠期碘含量充足)和对照组(碘含量低于150 μg/l)。对参与研究的妇女的儿童进行先天性甲状腺功能减退症新生儿筛查的结果进行了评估。观察组新生儿TSH高于5mIU/l的频率。进行roc分析,并建立新生儿TSH水平的“截断点”作为碘缺乏的指标。结果:秋明市孕妇尿碘浓度中位数为159.05 μg/l,甲状腺肿发生率为0.38%,新生儿甲状腺功能亢进5 mIU/l以上发生率为2.88%,表明孕妇尿碘摄入充足。主组妇女新生儿TSH高于5 mIU/l的发生率为1.47%,对照组为- 9.3% (p = 0.076)。ROC分析显示,截断点新生儿TSH阈值为2.77 mIU/l,与约登指数的最高值相对应。预测尿碘浓度大于150 μg/l,而nTSH值低于此值。结论:对新生儿先天性甲状腺功能减退症筛查数据库进行分析,可以有效、快速、低成本地每年评估人群的碘状况。在我们的工作中,在碘摄入充足的健康孕妇模型中,建立的新生儿TSH“截断点”为2.77 mIU/l,在妊娠期间不同碘水平的妇女中,新生儿甲状腺功能亢进症的发生率在5 mIU/l以上没有统计学上的显著差异,这表明有必要修改现有的5 mIU/l阈值,并可能是在不同碘供应地区进行大规模研究的动机。
{"title":"[Neonatal thyrotropin - indicatior of monitoring of iodine deficiency severity. What's level is considered a «cutoff point»?]","authors":"L A Suplotova,&nbsp;O B Makarova,&nbsp;A Troshina","doi":"10.14341/probl12892","DOIUrl":"https://doi.org/10.14341/probl12892","url":null,"abstract":"<p><strong>Background: </strong>The issues of monitoring the effectiveness of iodine deficiency prevention programs are an important component in the process of iodine elimination. Neonatal thyrotropin (TSH) has been used as a criterion for the severity of iodine deficiency since 1994, however, the question of the \"cut-off point\" of the neonatal TSH level has been widely discussed in the recent literature.</p><p><strong>Aim: </strong>Evaluate the criterion for neonatal hyperthyroidism above 5 mIU/l from the perspective of monitoring iodine deficiency and establish a «cut-off point» on the model of healthy pregnant women with adequate iodine status.</p><p><strong>Materials and methods: </strong>A prospective study was conducted in a population of pregnant women in the city of Tyumen, with the formation of observation groups according to the level of iodine excretion in the urine - the main group (with adequate iodine status throughout the entire gestation period) and the comparison group (women with iodine levels less than 150 μg/l). The results of neonatal screening for congenital hypothyroidism in children of women participating in the study were evaluated. The frequency of neonatal TSH above 5mIU/l was assessed in the observation groups. ROC-analysis was performed and a «cut-off point» of the level of neonatal TSH was established as an indicator of iodine deficiency.</p><p><strong>Results: </strong>The median urinary iodine concentration in the population of pregnant women in Tyumen was 159.05 μg/l, the incidence of goiter was 0.38%, the incidence of neonatal hyperthyroidism above 5 mIU/l was 2.88%, which characterizes adequate iodine intake in the pregnant population women. The frequency of neonatal TSH above 5 mIU/l in newborns from women from the main group was 1.47%, and in the comparison group - 9.3% (p = 0.076). ROC analysis revealed a threshold value of neonatal TSH of 2.77 mIU/l at the cut-off point, which corresponded to the highest value of the Youden index. Urinary iodine concentrations greater than 150 μg/l were predicted for nTSH values below this value.</p><p><strong>Conclusion: </strong>Analysis of databases of neonatal screening for congenital hypothyroidism makes it possible to effectively, quickly and at minimal cost annually assess the iodine status in the population. The established «cut-off point» of neonatal TSH in the model of healthy pregnant women with adequate iodine intake in our work is 2.77 mIU/l, the absence of statistically significant differences in the incidence of neonatal hyperthyroidism above 5 mIU/l from women with different iodine status during pregnancy indicate the need to revise the existing threshold of 5 mIU/l and may be an incentive to conduct large-scale studies in regions with different iodine supply.</p>","PeriodicalId":20433,"journal":{"name":"Problemy endokrinologii","volume":"68 6","pages":"12-21"},"PeriodicalIF":0.0,"publicationDate":"2022-07-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939958/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9314510","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Endocrine disorders in patients with transfusion-dependent hereditary anemias]. [输血依赖性遗传性贫血患者的内分泌紊乱]。
Q4 Medicine Pub Date : 2022-07-27 DOI: 10.14341/probl13149
A V Vitebskaya, Ekaterina S Bugakova, E A Pisareva, Yu V Tikhonovich

Often transfusions red blood cells in patients with hereditary anemias lead to iron overload, that can cause endocrine complications, such as growth retardation, hypothyroidism, hypogonadism, and disorders of carbohydrate metabolism.Clinical case 1. A boy with transfusion-dependent (TD) Diamond-Blackfan anemia at 16.3 years presented with impaired fasting glucose, growth hormone (GH) deficiency, hypogonadotropic hypogonadism; GH therapy was initiated. At the age of 16.8 years old secondary hypothyroidism, secondary hypocorticism and diabetes mellitus were diagnosed. At 17.2 years continuous glucose monitoring (CGM) detected glucose elevations up to 11.7 mmol/l. Therapy with GH and testosterone ethers was continued; levothyroxine and cortef were stopped by patient. At 17.9 years height was 163 cm; no data supporting hypothyroidism nor hypocorticism; glycaemia within goal range.Clinical case 2. A girl with TD beta-thalassemia major at the age of 11.5 years presented with GH deficiency; GH therapy has been conducted from 12.8 to 15.3 years of age. At 13.8 years retardation of pubertal development was diagnosed. At 15.0 hyperglycemia 7.2 mmol/l was detected; normal results of oral glucose tolerance test (OGTT) were observed; glycemia elevations were up to 9.5 mmol/l according to CGM data. At 16.0 height was 152 cm; because of pubertal development arrest hormone replacement therapy was prescribed.CONCLUSION. Growth, pubertal and carbohydrate metabolism disorders were diagnosed in patients with TD hereditary anemias, that confirms the necessity of regularly endocrine investigation. To detect impairment of carbohydrate metabolism investigation of fasting blood glucose, OGTT, and CGM is recommended; glycated hemoglobin measurement is not considered reasonable.

遗传性贫血患者经常输红细胞导致铁超载,从而引起内分泌并发症,如生长迟缓、甲状腺功能减退、性腺功能减退和碳水化合物代谢紊乱。临床病例1。1例16.3岁输血依赖性(TD) Diamond-Blackfan贫血的男孩,表现为空腹血糖受损、生长激素(GH)缺乏、促性腺功能低下;开始生长激素治疗。16.8岁时诊断为继发性甲状腺功能减退、继发性皮质功能减退、糖尿病。在17.2岁时,连续血糖监测(CGM)检测到血糖升高高达11.7 mmol/l。继续使用生长激素和睾酮醚治疗;患者停用左甲状腺素和cortef。17.9岁时身高163厘米;没有数据支持甲状腺功能减退或皮质减退;血糖在目标范围内。临床病例2。1例患有TD -地中海贫血的女孩,11.5岁时表现为生长激素缺乏症;生长激素治疗从12.8岁到15.3岁进行。13.8岁时被诊断为青春期发育迟缓。15.0时高血糖7.2 mmol/l;口服糖耐量试验(OGTT)正常;根据CGM数据,血糖升高高达9.5 mmol/l。16.0时身高152厘米;由于青春期发育停滞,给予激素替代治疗。TD遗传性贫血患者的生长发育、青春期发育及碳水化合物代谢紊乱均有诊断,证实了定期进行内分泌调查的必要性。为了检测碳水化合物代谢的损害,建议调查空腹血糖、OGTT和CGM;糖化血红蛋白测量被认为是不合理的。
{"title":"[Endocrine disorders in patients with transfusion-dependent hereditary anemias].","authors":"A V Vitebskaya,&nbsp;Ekaterina S Bugakova,&nbsp;E A Pisareva,&nbsp;Yu V Tikhonovich","doi":"10.14341/probl13149","DOIUrl":"https://doi.org/10.14341/probl13149","url":null,"abstract":"<p><p>Often transfusions red blood cells in patients with hereditary anemias lead to iron overload, that can cause endocrine complications, such as growth retardation, hypothyroidism, hypogonadism, and disorders of carbohydrate metabolism.Clinical case 1. A boy with transfusion-dependent (TD) Diamond-Blackfan anemia at 16.3 years presented with impaired fasting glucose, growth hormone (GH) deficiency, hypogonadotropic hypogonadism; GH therapy was initiated. At the age of 16.8 years old secondary hypothyroidism, secondary hypocorticism and diabetes mellitus were diagnosed. At 17.2 years continuous glucose monitoring (CGM) detected glucose elevations up to 11.7 mmol/l. Therapy with GH and testosterone ethers was continued; levothyroxine and cortef were stopped by patient. At 17.9 years height was 163 cm; no data supporting hypothyroidism nor hypocorticism; glycaemia within goal range.Clinical case 2. A girl with TD beta-thalassemia major at the age of 11.5 years presented with GH deficiency; GH therapy has been conducted from 12.8 to 15.3 years of age. At 13.8 years retardation of pubertal development was diagnosed. At 15.0 hyperglycemia 7.2 mmol/l was detected; normal results of oral glucose tolerance test (OGTT) were observed; glycemia elevations were up to 9.5 mmol/l according to CGM data. At 16.0 height was 152 cm; because of pubertal development arrest hormone replacement therapy was prescribed.CONCLUSION. Growth, pubertal and carbohydrate metabolism disorders were diagnosed in patients with TD hereditary anemias, that confirms the necessity of regularly endocrine investigation. To detect impairment of carbohydrate metabolism investigation of fasting blood glucose, OGTT, and CGM is recommended; glycated hemoglobin measurement is not considered reasonable.</p>","PeriodicalId":20433,"journal":{"name":"Problemy endokrinologii","volume":"68 6","pages":"121-130"},"PeriodicalIF":0.0,"publicationDate":"2022-07-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939971/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9299180","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Elimination of iodine deficiency is a concern for the health of the nation. An excursion into the history, scientific aspects and the current state of the legal regulation of the problem in Russia]. 消除碘缺乏症是国民健康的大事。游览历史,科学方面和现状的法律法规的问题在俄罗斯]。
Q4 Medicine Pub Date : 2022-07-27 DOI: 10.14341/probl13154
E A Troshina

The article presents current data on the prevalence of thyroid diseases associated with iodine deficiency in Russia, focuses on the features of the comorbidity of iodine deficiency and autoimmune thyroid pathologies, methods for assessing the iodine supply of the population. Information about the study and prevention of iodine deficiency diseases (IDD) in the USSR and the Russian Federation is given. The history of legislative initiatives aimed at eliminating dietary iodine deficiency and preventing IDD is illustrated in detail. The ways of solving the problem of iodine deficiency at the present stage, both at the federal and regional levels, are proposed.

这篇文章介绍了俄罗斯与碘缺乏相关的甲状腺疾病患病率的当前数据,重点介绍了碘缺乏和自身免疫性甲状腺病变共病的特点,以及评估人口碘供应的方法。介绍了在苏联和俄罗斯联邦研究和预防缺碘病的情况。详细说明了旨在消除膳食碘缺乏症和预防缺碘症的立法倡议的历史。提出了现阶段在联邦和地区两级解决缺碘问题的途径。
{"title":"[Elimination of iodine deficiency is a concern for the health of the nation. An excursion into the history, scientific aspects and the current state of the legal regulation of the problem in Russia].","authors":"E A Troshina","doi":"10.14341/probl13154","DOIUrl":"https://doi.org/10.14341/probl13154","url":null,"abstract":"<p><p>The article presents current data on the prevalence of thyroid diseases associated with iodine deficiency in Russia, focuses on the features of the comorbidity of iodine deficiency and autoimmune thyroid pathologies, methods for assessing the iodine supply of the population. Information about the study and prevention of iodine deficiency diseases (IDD) in the USSR and the Russian Federation is given. The history of legislative initiatives aimed at eliminating dietary iodine deficiency and preventing IDD is illustrated in detail. The ways of solving the problem of iodine deficiency at the present stage, both at the federal and regional levels, are proposed.</p>","PeriodicalId":20433,"journal":{"name":"Problemy endokrinologii","volume":"68 4","pages":"4-12"},"PeriodicalIF":0.0,"publicationDate":"2022-07-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9762445/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10483967","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
[Thyrotoxicosis in a patient with Turner syndrome: radioactive iodine therapy]. [特纳综合征患者的甲亢:放射性碘治疗]。
Q4 Medicine Pub Date : 2022-07-25 DOI: 10.14341/probl13132
R M Guseinova, A A Prosvirnina, M O Korchagina, A A Trukhin, M S Sheremeta

Turner syndrome (TS) is a chromosomal disorder affecting female and characterized by complete or partial monosomy of the X chromosome. These genetic changes lead to the abnormalities in growth and development and increase the risk of autoimmune diseases, including those affecting the thyroid. Thyroid pathology in TS may include autoimmune thyroiditis, hypothyroidism, thyrotoxicosis (Graves disease, AIT in the hyperthyroid state).Thyrotoxicosis is the clinical syndrome of excess circulating thyroid hormones. One of the main causes of thyrotoxicosis is Graves' disease (GD), an organ-specific autoimmune disease caused by the production of stimulating thyrotropin receptor antibodies. There are three treatment options for thyrotoxicosis: anti-thyroid drugs, radioactive iodine and thyroidectomy. A personalized approach to disease management is especially important in cases of genetic diseases.We present a clinical case of a patient with TS and GD, who has been referred to a radiologist at the Department of Radionuclide Therapy of Endocrinology Research Center. The patient was diagnosed with congenital hypothyroidism at neonatal screening, but thyroid hormones therapy was initiated aged three. Based on the survey, GD was diagnosed aged twenty one. Anti-thyroid drug therapy was started, which resulted in toxic hepatitis. Taking into account intolerance to anti-thyroid drugs, radioiodine therapy has been recommended, which led to hypothyroidism.

特纳综合征(TS)是一种影响女性的染色体疾病,其特征是X染色体完全或部分单体。这些基因变化会导致生长和发育异常,并增加患自身免疫性疾病(包括影响甲状腺的疾病)的风险。TS的甲状腺病变可能包括自身免疫性甲状腺炎、甲状腺功能减退症、甲状腺毒症(巴塞杜氏病、甲亢状态下的AIT)。引起甲亢的主要原因之一是巴塞杜氏病(GD),这是一种器官特异性自身免疫性疾病,由刺激性促甲状腺素受体抗体的产生引起。甲亢有三种治疗方法:抗甲状腺药物、放射性碘和甲状腺切除术。在遗传性疾病的病例中,个性化的疾病管理方法尤为重要。我们介绍了一例临床病例,患者患有TS和GD,内分泌学研究中心放射性核素治疗部的放射科医生将其转诊至该中心。该患者在新生儿筛查中被诊断为先天性甲状腺功能减退症,但在三岁时开始接受甲状腺激素治疗。根据调查,患者在 21 岁时被确诊为 GD。患者开始接受抗甲状腺药物治疗,结果导致中毒性肝炎。考虑到患者对抗甲状腺药物不耐受,建议患者接受放射性碘治疗,结果导致甲状腺功能减退。
{"title":"[Thyrotoxicosis in a patient with Turner syndrome: radioactive iodine therapy].","authors":"R M Guseinova, A A Prosvirnina, M O Korchagina, A A Trukhin, M S Sheremeta","doi":"10.14341/probl13132","DOIUrl":"10.14341/probl13132","url":null,"abstract":"<p><p>Turner syndrome (TS) is a chromosomal disorder affecting female and characterized by complete or partial monosomy of the X chromosome. These genetic changes lead to the abnormalities in growth and development and increase the risk of autoimmune diseases, including those affecting the thyroid. Thyroid pathology in TS may include autoimmune thyroiditis, hypothyroidism, thyrotoxicosis (Graves disease, AIT in the hyperthyroid state).Thyrotoxicosis is the clinical syndrome of excess circulating thyroid hormones. One of the main causes of thyrotoxicosis is Graves' disease (GD), an organ-specific autoimmune disease caused by the production of stimulating thyrotropin receptor antibodies. There are three treatment options for thyrotoxicosis: anti-thyroid drugs, radioactive iodine and thyroidectomy. A personalized approach to disease management is especially important in cases of genetic diseases.We present a clinical case of a patient with TS and GD, who has been referred to a radiologist at the Department of Radionuclide Therapy of Endocrinology Research Center. The patient was diagnosed with congenital hypothyroidism at neonatal screening, but thyroid hormones therapy was initiated aged three. Based on the survey, GD was diagnosed aged twenty one. Anti-thyroid drug therapy was started, which resulted in toxic hepatitis. Taking into account intolerance to anti-thyroid drugs, radioiodine therapy has been recommended, which led to hypothyroidism.</p>","PeriodicalId":20433,"journal":{"name":"Problemy endokrinologii","volume":"68 6","pages":"49-58"},"PeriodicalIF":0.0,"publicationDate":"2022-07-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939966/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9299173","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Myokines in obese adolescents with aerobic exercise]. [有氧运动中肥胖青少年的肌生长因子]。
Q4 Medicine Pub Date : 2022-07-24 DOI: 10.14341/probl13138
Yu V Kasyanova, O V Vasyukova, P L Okorokov, Z T Zuraeva, O B Bezlepkina

Background: Myokines are synthesized by myocytes and released into the bloodstream in response to muscle fiber contraction. They have a positive effect on carbohydrate and lipid metabolism, muscle mass growth, osteogenesis, increase tissue sensitivity to insulin, counteract inflammation of adipose tissue. The study of their secretion in response to physical activity (FA) can help to personalize the therapy of obesity.

Aim: to study the features of the secretion of myokines in children with constitutionally exogenous obesity during physical activity of different duration and intensity and to evaluate their relationship with the parameters of the body composition.

Materials and methods: 26 children (10 boys and 16 girls) were included in the study 15 [13; 16] years old, SDS BMI: +2.91 [2.24; 3.29], with sexual development according to Tanner 4-5. Two groups of 13 people were formed by random distribution. Group I performed FA (walking on a treadmill under the control of heart rate) of different duration: 30 and 60 minutes at the same intensity (less than 3 metabolic equivalents (MET)). Group II - FA of different intensity: low - less than 3 METH and moderate - 3-6 METH with the same duration of 45 minutes. Commercial kits for enzyme immunoassay were used to determine the level of myokines. The assessment of the compositional composition of the body was carried out by bioimpedance analysis (analyzer In Body 770, South Korea) in the morning, on an empty stomach. Statistical processing was carried out using STATISTICA v.12.0 (StatSoftInc., USA). The results are presented in the form of median (Me) and quartiles (Q1; Q3) corresponding to 25 and 75 percentiles. The critical significance level (p) was assumed to be <0.05.

Results: moderate intensity FA leads to a maximum increase in the level of myokines: interleukin-6 (IL-6) by 215.7% and decorin by 34.3%, a decrease in the level of irisin by 16.5%. An hour-long low-intensity workout leads to a moderate increase in the level of IL-6 by 80.5%, to a decrease in the level of irisin by 31.1%. Myostatin increases equally both after 60-minute FA and after moderate intensity FA by 30.9% and 31.8%, respectively. Short low-intensity FA (lasting 30 minutes) it is not accompanied by a significant increase in the expression of myokines. The relationship between the amount of muscle (r=0.65), lean (r=0.62), fat-free mass (r=0.64) and the level of decorin after FA was noted. There was no statistically significant relationship between the parameters of the body composition and the levels of IL-6, myostatin, and irisin. There were no gender differences in both basal and stimulated myokine secretion.

Conclusion: Moderate intensity FA and low intensity 60-minute FA are most effective for obese children. A 30-minute low-intensity FN is insufficient to increase the secretion of myokines by skeletal muscles.

背景:肌因子是由肌细胞合成并释放到血液中的肌肉纤维收缩的反应。它们对碳水化合物和脂质代谢、肌肉质量增长、成骨、增加组织对胰岛素的敏感性、抵消脂肪组织的炎症有积极作用。研究它们的分泌对身体活动(FA)的反应可以帮助个性化肥胖治疗。目的:研究体质外源性肥胖儿童在不同持续时间和强度的体育运动中肌因子的分泌特点,并评价其与身体组成参数的关系。材料与方法:26例儿童(男孩10例,女孩16例)纳入研究15 [13;16岁,SDS BMI: +2.91 [2.24;[3.29],根据Tanner 4-5的说法,性发育。随机分为两组,每组13人。第一组进行不同持续时间的FA(在心率控制的跑步机上行走):30分钟和60分钟,相同强度(小于3代谢当量(MET))。II组-不同强度的FA:低-小于3冰毒,中- 3-6冰毒,相同持续时间为45分钟。使用商业酶免疫测定试剂盒测定肌因子水平。上午空腹,通过生物阻抗分析(韩国770号体分析仪)对机体成分进行评估。使用STATISTICA v.12.0 (StatSoftInc)进行统计处理。美国)。结果以中位数(Me)和四分位数(Q1;Q3)对应25和75个百分位数。结果:中等强度FA导致肌因子水平最大升高:白介素-6 (IL-6)升高215.7%,decorin升高34.3%,鸢尾素水平下降16.5%。一小时的低强度锻炼导致IL-6水平适度上升80.5%,鸢尾素水平下降31.1%。肌肉生长抑制素在60分钟和中等强度的运动后分别平均增加30.9%和31.8%。短时间低强度FA(持续30分钟)不伴有肌因子表达的显著增加。观察FA后肌肉量(r=0.65)、瘦肉量(r=0.62)、无脂量(r=0.64)与decorin水平的关系。体成分参数与IL-6、肌生长抑制素、鸢尾素水平无统计学意义。在基础和刺激肌因子分泌方面没有性别差异。结论:中等强度FA和低强度FA治疗肥胖儿童最有效。30分钟的低强度FN不足以增加骨骼肌肌因子的分泌。
{"title":"[Myokines in obese adolescents with aerobic exercise].","authors":"Yu V Kasyanova,&nbsp;O V Vasyukova,&nbsp;P L Okorokov,&nbsp;Z T Zuraeva,&nbsp;O B Bezlepkina","doi":"10.14341/probl13138","DOIUrl":"https://doi.org/10.14341/probl13138","url":null,"abstract":"<p><strong>Background: </strong>Myokines are synthesized by myocytes and released into the bloodstream in response to muscle fiber contraction. They have a positive effect on carbohydrate and lipid metabolism, muscle mass growth, osteogenesis, increase tissue sensitivity to insulin, counteract inflammation of adipose tissue. The study of their secretion in response to physical activity (FA) can help to personalize the therapy of obesity.</p><p><strong>Aim: </strong>to study the features of the secretion of myokines in children with constitutionally exogenous obesity during physical activity of different duration and intensity and to evaluate their relationship with the parameters of the body composition.</p><p><strong>Materials and methods: </strong>26 children (10 boys and 16 girls) were included in the study 15 [13; 16] years old, SDS BMI: +2.91 [2.24; 3.29], with sexual development according to Tanner 4-5. Two groups of 13 people were formed by random distribution. Group I performed FA (walking on a treadmill under the control of heart rate) of different duration: 30 and 60 minutes at the same intensity (less than 3 metabolic equivalents (MET)). Group II - FA of different intensity: low - less than 3 METH and moderate - 3-6 METH with the same duration of 45 minutes. Commercial kits for enzyme immunoassay were used to determine the level of myokines. The assessment of the compositional composition of the body was carried out by bioimpedance analysis (analyzer In Body 770, South Korea) in the morning, on an empty stomach. Statistical processing was carried out using STATISTICA v.12.0 (StatSoftInc., USA). The results are presented in the form of median (Me) and quartiles (Q1; Q3) corresponding to 25 and 75 percentiles. The critical significance level (p) was assumed to be <0.05.</p><p><strong>Results: </strong>moderate intensity FA leads to a maximum increase in the level of myokines: interleukin-6 (IL-6) by 215.7% and decorin by 34.3%, a decrease in the level of irisin by 16.5%. An hour-long low-intensity workout leads to a moderate increase in the level of IL-6 by 80.5%, to a decrease in the level of irisin by 31.1%. Myostatin increases equally both after 60-minute FA and after moderate intensity FA by 30.9% and 31.8%, respectively. Short low-intensity FA (lasting 30 minutes) it is not accompanied by a significant increase in the expression of myokines. The relationship between the amount of muscle (r=0.65), lean (r=0.62), fat-free mass (r=0.64) and the level of decorin after FA was noted. There was no statistically significant relationship between the parameters of the body composition and the levels of IL-6, myostatin, and irisin. There were no gender differences in both basal and stimulated myokine secretion.</p><p><strong>Conclusion: </strong>Moderate intensity FA and low intensity 60-minute FA are most effective for obese children. A 30-minute low-intensity FN is insufficient to increase the secretion of myokines by skeletal muscles.</p>","PeriodicalId":20433,"journal":{"name":"Problemy endokrinologii","volume":"68 4","pages":"102-110"},"PeriodicalIF":0.0,"publicationDate":"2022-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10801742","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
[Pituitary and COVID-19: review]. [垂体与COVID-19:综述]。
Q4 Medicine Pub Date : 2022-07-20 DOI: 10.14341/probl13108
U V Buyvalenko, M A Perepelova, R A Zolotareva, Zh E Belaya, G A Melnichenko

A severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has rapidly spread around the world since was first scientifically described in December 2019. At present approximately 400 million people have suffered from the disease, almost 6 million people have died.SARS-CoV-2 uses the angiotensin-converting enzyme 2 (ACE2) and the serine protease TMPRSS2 for S protein priming. ACE2 and TMPRSS2 are expressed in several endocrine glands, including the pituitary, pancreas, thyroid, ovaries, and testes. Thus, the endocrine glands may be a direct target for SARS-CoV-2. The main risk factors for severity of the COVID-19 are obesity, arterial hypertension, diabetes mellitus (DM), vertebral fractures, which potentially predisposes patients to a severe course of COVID-19.In this review, we present current data on the course of COVID-19 in patients with hypothalamic-pituitary diseases, and also discuss treatment for endocrinopathies during to COVID-19.

自2019年12月首次被科学描述以来,严重急性呼吸综合征冠状病毒2型(严重急性呼吸系统综合征冠状病毒-2)已在世界各地迅速传播。目前约有4亿人患有这种疾病,近600万人死亡。严重急性呼吸系统综合征冠状病毒2型使用血管紧张素转换酶2(ACE2)和丝氨酸蛋白酶TMPRSS2进行S蛋白启动。ACE2和TMPRSS2在几种内分泌腺中表达,包括垂体、胰腺、甲状腺、卵巢和睾丸。因此,内分泌腺可能是严重急性呼吸系统综合征冠状病毒2型的直接靶点。新冠肺炎严重程度的主要危险因素是肥胖、动脉高血压、糖尿病(DM)、脊椎骨折,这可能使患者容易患上严重的新冠肺炎。在这篇综述中,我们提供了有关下丘脑-肠疾病患者新冠肺炎病程的最新数据,并讨论了新冠肺炎期间内分泌疾病的治疗。
{"title":"[Pituitary and COVID-19: review].","authors":"U V Buyvalenko,&nbsp;M A Perepelova,&nbsp;R A Zolotareva,&nbsp;Zh E Belaya,&nbsp;G A Melnichenko","doi":"10.14341/probl13108","DOIUrl":"10.14341/probl13108","url":null,"abstract":"<p><p>A severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has rapidly spread around the world since was first scientifically described in December 2019. At present approximately 400 million people have suffered from the disease, almost 6 million people have died.SARS-CoV-2 uses the angiotensin-converting enzyme 2 (ACE2) and the serine protease TMPRSS2 for S protein priming. ACE2 and TMPRSS2 are expressed in several endocrine glands, including the pituitary, pancreas, thyroid, ovaries, and testes. Thus, the endocrine glands may be a direct target for SARS-CoV-2. The main risk factors for severity of the COVID-19 are obesity, arterial hypertension, diabetes mellitus (DM), vertebral fractures, which potentially predisposes patients to a severe course of COVID-19.In this review, we present current data on the course of COVID-19 in patients with hypothalamic-pituitary diseases, and also discuss treatment for endocrinopathies during to COVID-19.</p>","PeriodicalId":20433,"journal":{"name":"Problemy endokrinologii","volume":"68 5","pages":"14-23"},"PeriodicalIF":0.0,"publicationDate":"2022-07-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10453212","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Problemy endokrinologii
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1